Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Disorders of Leukocytes01:27

Disorders of Leukocytes

947
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
947
Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms.

Cancer cell·2026
Same author

Assessing the contributions of noncoding RNAs in acute myeloid leukemia.

Blood neoplasia·2026
Same author

Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Loss of cystathionine-β-synthase contributes to elevated OXPHOS, a vulnerability in Ara-C-resistant Myeloid Leukemia in Down syndrome.

Biochemical pharmacology·2026
Same author

The GATA1 N terminus coordinates metabolic reprogramming in erythropoiesis.

Blood·2026
Same author

FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome.

The Journal of clinical investigation·2026

相关实验视频

Updated: Jun 30, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

前白血病疾病的恶性进展.

Trent Hall1, Sandeep Gurbuxani2, John D Crispino1

  • 1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.

Blood
|March 18, 2024
PubMed
概括

了解骨髓疾病从骨髓衰竭到急性骨髓白血病的进展至关重要. 研究强调了克隆突变,遗传因素和骨髓环境在疾病发展中的作用.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 遗传学 是一个遗传学.

背景情况:

  • 骨髓瘤疾病涵盖从骨髓衰竭到急性骨髓白血病 (AML) 的范围.
  • 最近的单细胞和批量测序进步为AML转型提供了洞察力.
  • 细菌线倾向和癌前状态模型AML的进展.

研究的目的:

  • 审查驱动从癌前状态到急性髓性白血病进展的机制.
  • 专注于克隆层次,遗传改变和骨髓微环境.
  • 确定防止AML进展或治疗已确定的白血病的未满足需求.

主要方法:

  • 对有关髓性疾病进展的现有文献的综述.
  • 分析包括生殖线倾向,癌前状态和骨髓位综合征在内的模型.
  • 专注于遗传突变 (转录因子,拼接因子) 和环境影响.

主要成果:

  • 进展到AML涉及到克隆突变的逐步积累.
  • 转录因子和拼接因子的变化起着重要的作用.
  • 骨髓微环境是疾病进展的关键因素.

结论:

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

相关实验视频

Last Updated: Jun 30, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.2K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
  • 了解AML的进展需要整合遗传和环境因素.
  • 尽管取得了进展,但有效的AML预防和治疗策略仍然是一个重大未满足的需求.
  • 对突变和微环境影响等级的进一步研究是有必要的.